Efficacy of non-Hodgkin’s lymphoma cancer vaccine demonstrated in dogs
An experimental vaccine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin’s lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types.
Efficacy of non-Hodgkin’s lymphoma cancer vaccine demonstrated in dogs Read More »